Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain scans reveal how PTSD patients learn to avoid threats

NCT ID NCT04770584

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how people with PTSD learn to avoid certain situations, using mild electric shocks and brain scans. Researchers will measure stress responses and brain activity in 300 adults as they learn to avoid shocks by pressing a button. The goal is to understand the brain processes behind avoidance and fear, which may help improve future treatments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help researchers better understand how PTSD affects learning and avoidance, potentially pointing toward new therapy targets.
What could go wrong
This is an early-stage observational study, not a treatment trial. It measures brain activity and stress responses, so it won't directly improve symptoms. Results may not apply to all PTSD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2021

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. 18 - 70 years of age 2. Female or Male 3. Inclusion Criteria: PTSD Subjects a. Diagnosis of current PTSD 4. Inclusion Criteria: Trauma-exposed healthy controls (TEHC) 1. SCID diagnosis consistent with no current psychiatric disorders, and no current PTSD 2. History of trauma exposure 5. Inclusion Criteria: Healthy controls (HC) 1. SCID diagnosis consistent with no current psychiatric disorders ("Axis I" disorders). 2. No history of trauma exposure 6. Willing and able to provide informed consent. Exclusion Criteria for ALL subjects: 1. History of neurologic disease (e.g. tic disorder) 2. Current significant suicidal ideation, plan or intent or suicidal behavior in past 6 months based on CSSRS or Self-injurious behavior that involves suicidal intent, requires medical attention, or occurs daily 3. History of seizure or significant head trauma 4. History of the serious/significant psychiatric diagnosis ("Axis I" disorders) 5. Use of neuroleptics within one year prior to study 6. Current substance use (assessed by urine toxicology; positive urine toxicology screen for any substance, with the exception of THC). Per PI judgement and approval: if urine toxicology is positive for a substance, participant may be eligible to proceed with study provided their urine toxicology (or saliva test for THC) is negative at experimental visit(s) 7. Pregnancy (to be ruled out by urine ß-HCG) 8. Metallic implants or devices contraindicating magnetic resonance imaging 9. High risk of adverse emotional or behavioral reaction, and/or an inability to understand study procedures or the informed consent process Additional exclusion criteria for Trauma-exposed healthy controls (TEHC) group and Healthy controls (HC) group: 10. Current psychiatric diagnosis ("Axis I" diagnoses)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-traumatic stress disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UTHealth Houston

    RECRUITING

    Houston, Texas, 77054, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.